The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat<sup>®</sup>, have failed in Phase III clinical trials. As an alternative strategy, recent efforts have been focu...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2020-12-01
|
| Серія: | Pharmaceuticals |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1424-8247/14/1/31 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|